These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 22030011

  • 1. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands.
    Kang KY, Kim HO, Kwok SK, Ju JH, Park KS, Sun DI, Jhun JY, Oh HJ, Park SH, Kim HY.
    Arthritis Res Ther; 2011; 13(5):R179. PubMed ID: 22030011
    [Abstract] [Full Text] [Related]

  • 2. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
    Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Giardina A, Sireci G, Campisi G, De Leo G, Triolo G.
    Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
    [Abstract] [Full Text] [Related]

  • 3. cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
    Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.
    Clin Exp Immunol; 2017 Oct; 190(1):96-109. PubMed ID: 28621822
    [Abstract] [Full Text] [Related]

  • 4. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM, Hillen MR, Kruize AA, Meller S, Homey B, Smithson GM, Radstake TRDJ, van Roon JAG.
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, Lafeber FP, van Roon JA.
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [Abstract] [Full Text] [Related]

  • 6. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
    Verstappen GM, Gao L, Pringle S, Haacke EA, van der Vegt B, Liefers SC, Patel V, Hu Y, Mukherjee S, Carman J, Menard LC, Spijkervet FKL, Vissink A, Bootsma H, Kroese FGM.
    Front Immunol; 2021 Apr; 12():681941. PubMed ID: 34295332
    [Abstract] [Full Text] [Related]

  • 7. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C.
    Arthritis Res Ther; 2004 Apr; 6(5):R447-56. PubMed ID: 15380044
    [Abstract] [Full Text] [Related]

  • 8. IL-21 and Sjögren's syndrome.
    Scofield RH.
    Arthritis Res Ther; 2011 Apr; 13(6):137. PubMed ID: 22226370
    [Abstract] [Full Text] [Related]

  • 9. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM, Kislat A, Homey B, Smithson GM, Kruize AA, Radstake TRDJ, van Roon JAG.
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [Abstract] [Full Text] [Related]

  • 10. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH, Lee YJ, Hyon JY, Yun PY, Song YW.
    Clin Exp Rheumatol; 2011 Mar; 29(6):970-6. PubMed ID: 22132900
    [Abstract] [Full Text] [Related]

  • 11. Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjögren's syndrome patients.
    Nakamura H, Hasegawa H, Sasaki D, Takatani A, Shimizu T, Kurushima S, Horai Y, Nakashima Y, Nakamura T, Fukuoka J, Kawakami A.
    Clin Exp Rheumatol; 2018 Mar; 36 Suppl 112(3):51-60. PubMed ID: 29600938
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.
    Maehara T, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Tanaka A, Shinozaki S, Kubo Y, Nakamura S.
    Ann Rheum Dis; 2012 Dec; 71(12):2011-19. PubMed ID: 22753386
    [Abstract] [Full Text] [Related]

  • 13. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
    Skarstein K, Aqrawi LA, Øijordsbakken G, Jonsson R, Jensen JL.
    Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
    Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE.
    J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
    [Abstract] [Full Text] [Related]

  • 15. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
    Cortés J, Hidalgo J, Aguilera S, Castro I, Brito M, Urra H, Pérez P, Barrera MJ, Carvajal P, Urzúa U, González S, Molina C, Bahamondes V, Hermoso M, González MJ.
    J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
    Park JS, Kim SM, Choi J, Jung KA, Hwang SH, Yang S, Kwok SK, Cho ML, Park SH.
    Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
    [Abstract] [Full Text] [Related]

  • 17. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
    Kim DS, Woo JS, Min HK, Choi JW, Moon JH, Park MJ, Kwok SK, Park SH, Cho ML.
    J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
    [Abstract] [Full Text] [Related]

  • 18. Role of fractalkine in the pathogenesis of primary Sjögren syndrome: increased serum levels of fractalkine, its expression in labial salivary glands, and the association with clinical manifestations.
    Lee JH, Kwok SK, Jung SM, Lee J, Lee JS, Baek SY, Kim EK, Ju JH, Park SH, Kim HY.
    J Rheumatol; 2014 Dec; 41(12):2425-38. PubMed ID: 25320221
    [Abstract] [Full Text] [Related]

  • 19. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
    Awada A, Nicaise C, Ena S, Schandéné L, Rasschaert J, Popescu I, Gangji V, Soyfoo MS.
    Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
    [Abstract] [Full Text] [Related]

  • 20. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A, Kruize AA, Wenting M, Versnel MA, Bijlsma JW, Lafeber FP, van Roon JA.
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.